Page last updated: 2024-08-22
stavudine and hi 236
stavudine has been researched along with hi 236 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Anderson, KS; Bailey, CM; Basavapathruni, A; Hale, I; Hunter, R; Muhanji, CI | 1 |
| Anderson, KS; Bailey, CM; Hale, I; Hunter, R; Muhanji, CI; Singh, R; Sullivan, TJ; Younis, Y | 1 |
Other Studies
2 other study(ies) available for stavudine and hi 236
| Article | Year |
|---|---|
[d4U]-butyne-[HI-236] as a non-cleavable, bifunctional NRTI/NNRTI HIV-1 reverse-transcriptase inhibitor.
Topics: Anti-HIV Agents; Cell Line; Chemistry, Pharmaceutical; Dimerization; Drug Design; HIV Reverse Transcriptase; Humans; Models, Chemical; Molecular Conformation; Nucleosides; Pyridines; Reverse Transcriptase Inhibitors; Thiourea; Virus Replication | 2007 |
[d4U]-spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase.
Topics: Anti-HIV Agents; Binding Sites; Cell Line; Computer Simulation; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Polyethylene Glycols; Pyridines; Reverse Transcriptase Inhibitors; Thiourea | 2010 |